Novo Nordisk
NVO Large CapHealthcare · Drug Manufacturers - General
Updated: Apr 5, 2026, 00:03 UTC
Key Metrics
Valuation Analysis
🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →
About the Company
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, La
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
Where can I buy Novo Nordisk?
Compare top-rated brokers — low fees, trusted providers, fully regulated.